A detailed history of Roman Butler Fullerton & CO transactions in Johnson & Johnson stock. As of the latest transaction made, Roman Butler Fullerton & CO holds 12,669 shares of JNJ stock, worth $1.96 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
12,669
Previous 12,625 0.35%
Holding current value
$1.96 Million
Previous $1.85 Million 11.27%
% of portfolio
0.61%
Previous 0.63%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$145.48 - $167.38 $6,401 - $7,364
44 Added 0.35%
12,669 $2.05 Million
Q2 2024

Jul 15, 2024

SELL
$144.38 - $157.78 $19,924 - $21,773
-138 Reduced 1.08%
12,625 $1.85 Million
Q1 2024

Apr 29, 2024

SELL
$155.22 - $162.74 $10,399 - $10,903
-67 Reduced 0.52%
12,763 $2.02 Million
Q4 2023

Jan 31, 2024

SELL
$145.6 - $158.88 $61,006 - $66,570
-419 Reduced 3.16%
12,830 $2.01 Million
Q3 2023

Oct 18, 2023

SELL
$155.75 - $174.48 $96,720 - $108,352
-621 Reduced 4.48%
13,249 $2.06 Million
Q2 2023

Jul 25, 2023

SELL
$154.35 - $166.11 $64,981 - $69,932
-421 Reduced 2.95%
13,870 $2.3 Million
Q1 2023

Apr 27, 2023

BUY
$151.05 - $180.26 $256,180 - $305,720
1,696 Added 13.47%
14,291 $2.22 Million
Q4 2022

Jan 23, 2023

BUY
$160.2 - $179.79 $159,078 - $178,531
993 Added 8.56%
12,595 $0
Q3 2022

Oct 17, 2022

BUY
$161.33 - $179.52 $40,493 - $45,059
251 Added 2.21%
11,602 $1.89 Million
Q2 2022

Jul 26, 2022

BUY
$168.19 - $186.01 $20,855 - $23,065
124 Added 1.1%
11,351 $2.02 Million
Q1 2022

May 05, 2022

SELL
$158.14 - $179.59 $92,828 - $105,419
-587 Reduced 4.97%
11,227 $1.99 Million
Q4 2021

Jan 24, 2022

BUY
$155.93 - $173.01 $80,303 - $89,100
515 Added 4.56%
11,814 $2.02 Million
Q3 2021

Nov 10, 2021

SELL
$161.5 - $179.47 $75,905 - $84,350
-470 Reduced 3.99%
11,299 $1.81 Million
Q2 2021

Jul 29, 2021

SELL
$159.48 - $171.07 $3,986 - $4,276
-25 Reduced 0.21%
11,769 $1.94 Million
Q1 2021

Apr 22, 2021

BUY
$153.07 - $170.48 $10,255 - $11,422
67 Added 0.57%
11,794 $1.89 Million
Q4 2020

Feb 01, 2021

BUY
$137.11 - $157.38 $3,976 - $4,564
29 Added 0.25%
11,727 $1.85 Million
Q3 2020

Oct 15, 2020

SELL
$140.38 - $153.83 $6,176 - $6,768
-44 Reduced 0.37%
11,698 $1.74 Million
Q2 2020

Jul 28, 2020

BUY
$128.81 - $155.51 $100,858 - $121,764
783 Added 7.14%
11,742 $1.65 Million
Q1 2020

Apr 13, 2020

SELL
$111.14 - $153.99 $42,122 - $58,362
-379 Reduced 3.34%
10,959 $1.44 Million
Q4 2019

Jan 27, 2020

SELL
$127.5 - $146.44 $54,952 - $63,115
-431 Reduced 3.66%
11,338 $1.65 Million
Q3 2019

Oct 15, 2019

SELL
$126.95 - $142.14 $126,061 - $141,145
-993 Reduced 7.78%
11,769 $1.52 Million
Q2 2019

Jul 22, 2019

BUY
$131.15 - $144.24 $22,164 - $24,376
169 Added 1.34%
12,762 $1.78 Million
Q1 2019

Apr 24, 2019

BUY
$125.72 - $139.79 $23,509 - $26,140
187 Added 1.51%
12,593 $1.76 Million
Q4 2018

Feb 04, 2019

BUY
$122.84 - $147.84 $1.52 Million - $1.83 Million
12,406 New
12,406 $1.61 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Roman Butler Fullerton & CO Portfolio

Follow Roman Butler Fullerton & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

News

Stay updated on Roman Butler Fullerton & CO with notifications on news.